Social Impact Partners (SIP), a Hong Kong-based venture philanthropy organization supported by several private equity firms, has been drawing on industry resources to support portfolio organizations that face financial and operational challenges because of COVID-19.
“It’s not just a matter of surviving as a business but also achieving the social impact needs of beneficiaries,” said Lindy Lek, executive director of SIP. “When we talk to them about pivoting...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.